⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in March 2026
accessnewswire.com
JNJ
TAK
Orthopedic Power Tools Market to Reach USD 2,275.91 Million by 2032 on Back of Robotics and Minimally Invasive Surgery Adoption - Credence Research Inc.
prnewswire.com
ZBH
JNJ
Global Neuromodulation Devices Market Anticipating Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight
globenewswire.com
BSX
MDT
ABT
LIVN
JNJ
STC
PEN
Bayer Alleges J&J’s Claims Regarding NUBEQA ® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA
businesswire.com
JNJ
HOUSE OF ROSE PROFESSIONAL ANNOUNCES 2026 BREAK THE CEILING TOUCH THE SKY® 101 BEST GLOBAL COMPANIES FOR WOMEN IN LEADERSHIP INDEX (BTC 101 GLOBAL INDEX)
prnewswire.com
WMT
KO
PEP
CI
PG
AMZN
RCL
JNJ
ACN
Subcutaneous RYBREVANT®▼ (amivantamab) approved by European Commission for every-three-week and every-four-week dosing for patients with advanced EGFR-mutated non-small cell lung cancer
globenewswire.com
JNJ
BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting
accessnewswire.com
AMRX
JNJ
PFE
BMY
Health and Wellness Industry Report 2026-2035: A $10.35+ Trillion Market by 2030 Featuring Major Players Such as with Abbott Laboratories, L'Oreal, Nestle, General Mills, Omron, Philips, J&J
globenewswire.com
ABT
JNJ
TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
prnewswire.com
JNJ
The Mind Behind the Money: How Brian Spira Spent 30 Years Reshaping Litigation Finance and Legal Operations
globenewswire.com
JNJ